These findings simultaneously track temporal alterations in two key transcription factors involved in T2DM and highlight that increased NF-κB and blunted Nrf2-mediated antioxidant responses are key contributors to T2DM. The gene discussed is NFE2L2; the disease is type 2 diabetes mellitus.